Effects of hyaluronan-fortified surfactant in ventilated premature piglets with respiratory distress

Biology of the Neonate

Volumn 89, Issue 1, 2006, Pages 15-24

  Wang, Xiaoning ^a   Sun, Zhonghou ^a   Qian, Liling ^a   Guo, Chunbao ^a   Yu, Wenliang ^a   Wang, Wei ^a   Lu, Karen W ^b   Taeusch, H William ^b   Sun, Bo ^a,c  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

Hyaluronan; Pulmonary surfactant; Respiratory distress syndrome; Respiratory therapy

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 8; MESSENGER RNA; PORACTANT; SURFACTANT; TUMOR NECROSIS FACTOR ALPHA;

AERATION; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CONTROLLED STUDY; CYTOLOGY; HISTOLOGY; LUNG COMPLIANCE; LUNG INJURY; NEWBORN; NONHUMAN; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY DISTRESS SYNDROME; SURFACE TENSION;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL PRODUCTS; DISEASE MODELS, ANIMAL; HUMANS; HYALURONIC ACID; INFANT, NEWBORN; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; MALONDIALDEHYDE; PEROXIDASE; PHOSPHOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RNA, MESSENGER; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 30644464313     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088194     Document Type: Article

References (43)

1. Creuwels LA, van Golde LM, Haagsman HP: The pulmonary surfactant system. Lung 1997; 175:1-39.
2. Rider E, Jobe A, Ikegami M, Sun B: Different ventilation strategies alter surfactant response in preterm rabbits. J Appl Physiol 1992;73: 2089-2096.
3. Ikegami M, Kollapru S, Michna J, Jobe AH: Lung injury and surfactant metabolism after hyperventilation of premature lambs. Pediatr Res 2000;47:398-410.
4. Jobe AH, Ikegami M: Mechanism initiating lung injury in the preterm infants. Early Hum Dev 1998;53:81-94.
5. Spragg RG, Smith RM: Pathology of the surfactant system of the mature lung. Am J Respir Crit Care Med 1997;155:756-760.
6. Lu KW, Taeusch HW, Robertson B: Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries. Am J Respir Crit Care Med 2001;164:1531-1536.
7. Taeusch HW, Lu KW: Beneficial effects of adding dextran to Curosurf in a rat model of meconium aspiration (abstract). Biol Neonate 2002;81:39.
8. Kobayashi T, Ohta K, Tashiro K: Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract. J Appl Physiol 1999;86:1778-1784.
9. Bray AB: The role of hyaluronan in the pulmonary alveolus. J Theor Biol 2001;210:121-130.
10. Lu KW, Goerke J, Clements JA, Taeusch HW: Hyaluronan decreases surfactant inactivation in vitro. Pediatr Res 2005;57:237-241.
11. Lu KW, Goerke J, Clements JA, Taeusch HW: Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium injury. Pediatr Res 2005;58:206-210.
12. Bracci R: Free oxygen radicals and surfactant. Bio Neonate 1997;71(suppl):23-27.
13. Rogers MS, Mongelli JM, Tsang KH, Wang CC, Law KP: Lipid peroxidation in cord blood at birth: the effect of labour. Br J Obstet Gynaecol 1998;105:739-744.
14. Tullus K, Noack GW, Burman LG, Nilsson R, Wretlind B, Brauner A: Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 1996;155: 112-116.
15. McColm J, Stenson BJ, Biermasz N, McIntosh N: Measurement of interleukin-10 in bronchoalveolar lavage from preterm ventilated infants. Arch Dis Child Fetal Neonatal Ed 2000; 82:F156-F159.
16. Beresford MW. Shaw NJ: Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res 2002;52:973-978.
17. Robertson B, Curstedt T, Johansson J: Structural and functional characterization of porcine surfactant isolated by liquid-gel chromatography. Prog Respir Res 1990;25:237-246.
18. Zhu GF, Sun B, Niu SF, Lin K, Lindwall R, Robertson B: Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158: 437-443.
19. Zhou ZH, Sun B, Lin K, Zhu L: Prevention of rabbit acute lung injury by surfactant, inhaled nitric oxide and pressure support ventilation. Am J Respir Crit Care Med 2000;161:581-588.
20. Jean D, Maitre B, Tankovic J, Meignan M, Adnot S, Brun-Buisson C, Harf A, Delclaux C: Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearance. Crit Care Med 2002;30:442-447.
21. Mason RJ, Nellenbogen J, Clements JA: Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 1976;17:281-284.
22. Bartlett GB: Phosphorous assay in column chromatography. J Biol Chem 1959;234:466-468.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
24. Grisham MB, Benoit JN, Granger DN: Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 1990;186:729-742.
25. Hachimoku K: Peracid lipid assay. J Med Technol 1979;23:115-120.
26. Paananen R, Glumoff V, Sormunen R, Voorhout W, Hallman M: Expression and localization of lung surfactant protein B in Eustachian tube epithelium. Am J Physiol 2001;280: L214-L220.
27. Vezina SA, Roberge D, Fournier M, Dea S, Oth D, Archambault D: Cloning of porcine cytokine-specific cDNAs and detection of porcine tumor necrosis factor-α, interleukin (IL)-6, and IL-1β gene expression by reverse transcription PCR and chemiluminescence hybridization. Clin Diagn Lab Immunol 1995;2:665-671.
28. Ennema JJ, Kobayashi T, Robertson B, Curstedt T: Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia. Acta Anaesthesiol Scand 1988;32: 665-671.
29. Williams MC, Hawgood S, Hamilton RL: Changes in lipid structure produced by surfactant proteins SP-A, SP-B and SP-C. Am J Respir Cell Mol Biol 1991;5:41-50.
30. Venkitaraman AR, Hall SB, Whitsett JA, Notter RH: Enhanced biophysical activity of lung surfactant extracts and phospholipids-apoprotein mixtures by surfactant protein A. Chem Phys Lipids 1990;56:185-194.
31. Poulain FR, Nir S, Hawgood S: Kinetics of phospholipids membrane fusion induced by surfactant apoproteins A and B. Biochim Biophys Acta 1996;1278:169-175.
32. De Beaufort AJ, Bakker AC, van Toi MJD, Poorthuis BJ, Schrama AJ, Berg HM: Meconium is a source of pro-inflammatory substances and can induce cytokine production in cultured A549 epithelial cells. Pediatr Res 2003;54:491-495.
33. Donnelly SC, Stricter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993;341:643-647.
34. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ: Increase in interleukin-1β and interleukin-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996;40:250-256.
35. Cao L, Liu CQ, Cai BQ, Jia XQ, Kang LM, Speer CP. Sun B: Nuclear factor-κB expression in alveolar macrophages of mechanically ventilated neonates with respiratory distress syndrome. Biol Neonate 2004;86:116-123.
36. Murch SH, Costeloe K, Klein NJ, MacDonald TT: Early production of macrophage inflammatory protein 1α occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res 1996;40:490-497.
37. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA: Undetectable interleukin-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39:966-975.
38. Smits NC, Robbesom AA, Versteeg EMM, Van der Vesterlo EMA, Dekhuijzen PNR, Van Kuppeveit TH: Heterogeneity of heparan sulfates in human lung. Am J Respir Cell Mol Biol 2004;30:166-173.
39. Mascarenhas MM, Day RM, Choa CD, Choi WI, Yu L, Ouyang B, Garg HG, Hales CA, Quinn DA: Low molecular weight hyaluronan from stretched lung enhances IL-8 expression. Am J Respir Cell Mol Biol 2004;30:51-60.
40. Pasquali-Ronchetti I, Quaglino D, Mori G, Bacchelli B, Ghosh P: Hyaluronan-phospholipid interactions. J Struct Biol 1997;120:1-10.
41. Nitzan DW, Nitzan U, Dan P, Yedgar S: The role of hyaluronic acid in protecting surface-active phospholipids from lysis by exogenous phospholipase A2. Rheumatology 2001;40: 336-340.
42. Zasadzinski J, Alig TF, Alonso C, de la Serna JB, Perez-Gil J, Taeusch HW: Inactivation of pulmonary surfactant by serum: Mechanisms of reduced adsorption and its reversal by hydrophilic polymers - Part 2. Therory. Biophys J, in press.
43. Zasadzinski JA, Taeusch HW: Polymer depletion forces and surfactant adsorption. Polymer Preprints 2005, in press.